A new trial just getting underway at Scripps Research Institute in La Jolla is using two novel medications in combination to ...

A University of Pennsylvania biotechnology company that aims to treat autoimmune diseases by reengineering cells within the ...

Crispr Therapeutics AG ( ($CRSP) ) has risen by 7.26%. Read on to learn why. Crispr Therapeutics AG has seen a notable ...

A novel chimeric antigen receptor T-cell therapy may benefit patients with B-cell lymphomas who previously relapsed following ...

While data is promising, many questions remain about topics such as timing and doses in the treatment of hematologic malignancies.

A team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...

During a live event, Priyanka Pophali, MD, MBBS, discussed CAR T-cell therapy referrals, timing, and challenges in relapsed ...

A team of physicians recently reported the successful treatment of refractory autoimmune neuropathies through the infusion of ...

From FDA approvals streamlining access to critical therapies to new breakthroughs in challenging malignancies, the field of cancer care continues to demonstrate remarkable progress.

A Martin County family with a child fighting rare cancer is getting help from the community to get treatment abroad.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $69.0, a high ...

Previously, due to the risk of cytokine release syndrome and neurological toxicities, many CAR T-cell therapies included a REMS requirement.